2023 - Research.com Medicine in Netherlands Leader Award
Eric Boersma spends much of his time researching Internal medicine, Cardiology, Myocardial infarction, Surgery and Coronary artery disease. His studies in Heart failure, Percutaneous coronary intervention, Angina, Hazard ratio and Heart disease are all subfields of Internal medicine research. All of his Cardiology and Ejection fraction, Revascularization, Angioplasty, Cardiac resynchronization therapy and Dobutamine investigations are sub-components of the entire Cardiology study.
His research integrates issues of Odds ratio and Stroke in his study of Myocardial infarction. Eric Boersma interconnects Incidence and Risk factor in the investigation of issues within Surgery. As a part of the same scientific family, Eric Boersma mostly works in the field of Coronary artery disease, focusing on Radiology and, on occasion, Predictive value of tests and Coronary arteries.
The scientist’s investigation covers issues in Internal medicine, Cardiology, Myocardial infarction, Surgery and Coronary artery disease. His work in the fields of Internal medicine, such as Heart failure, Percutaneous coronary intervention, Ejection fraction and Acute coronary syndrome, overlaps with other areas such as In patient. His work in Heart failure addresses subjects such as Clinical endpoint, which are connected to disciplines such as Prospective cohort study.
Many of his studies on Cardiology apply to Hazard ratio as well. His Myocardial infarction research includes elements of Odds ratio and Randomized controlled trial. Eric Boersma combines subjects such as Intravascular ultrasound, Radiology and Artery with his study of Coronary artery disease.
His primary scientific interests are in Internal medicine, Cardiology, Heart failure, Acute coronary syndrome and Clinical endpoint. His work in Coronary artery disease, Biomarker, Hazard ratio, Myocardial infarction and Prospective cohort study are all subfields of Internal medicine research. His research investigates the connection with Myocardial infarction and areas like Meta-analysis which intersect with concerns in MEDLINE.
Eric Boersma conducted interdisciplinary study in his works that combined Cardiology and In patient. His study looks at the relationship between Heart failure and topics such as Interquartile range, which overlap with Troponin T. In his study, Randomized controlled trial is inextricably linked to Physical therapy, which falls within the broad field of Acute coronary syndrome.
His main research concerns Internal medicine, Cardiology, Clinical endpoint, Heart failure and Coronary artery disease. Internal medicine is represented through his Biomarker, Hazard ratio, Prospective cohort study, Myocardial infarction and Acute coronary syndrome research. As part of his studies on Cardiology, Eric Boersma often connects relevant areas like Stroke.
His Clinical endpoint research incorporates themes from Red blood cell distribution width and Framingham Risk Score. Eric Boersma works mostly in the field of Heart failure, limiting it down to topics relating to Outpatient clinic and, in certain cases, Heart disease, as a part of the same area of interest. The Coronary artery disease study combines topics in areas such as Coronary arteries, Adverse effect, Oxidized ldl and Revascularization.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
A prospective survey of patients with valvular heart disease in Europe : The Euro Heart Survey on Valvular Heart Disease.
Bernard Iung;Gabriel Baron;Eric G. Butchart;François Delahaye.
European Heart Journal (2003)
Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes
J.P. Bassand;C.W. Hamm;D. Ardissino;E. Boersma.
European Heart Journal (2007)
Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study
Joost Daemen;Peter Wenaweser;Keiichi Tsuchida;Linda Abrecht.
The Lancet (2007)
The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery
Poldermans D;Boersma E;Bax Jj;Thomson Ir.
The New England Journal of Medicine (1999)
Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour.
Eric Boersma;Arthur Cp Maas;Jaap W Deckers;Maarten L Simoons.
The Lancet (1996)
Percutaneous Coronary Intervention of Functionally Nonsignificant Stenosis: 5-Year Follow-Up of the DEFER Study
Nico H.J. Pijls;Pepijn van Schaardenburgh;Ganesh Manoharan;Eric Boersma.
Journal of the American College of Cardiology (2007)
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
Christian W. Hamm;Jean-Pierre Bassand;Stefan Agewall;Jeroen Bax.
Revista Espanola De Cardiologia (2012)
Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery?
Bernard Iung;Agnès Cachier;Gabriel Baron;David Messika-Zeitoun.
European Heart Journal (2005)
Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials
Eric Boersma;Robert A Harrington;David J Moliterno;Harvey White.
The Lancet (2002)
Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy
Jeroen J. Bax;Gabe B. Bleeker;Thomas H. Marwick;Sander G. Molhoek.
Journal of the American College of Cardiology (2004)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: